Fungemia | The fungal infection in the blood

The condition in which fungi are present in the blood is known as Fungemia. This pathogenic fungemia or fungal infection in the blood caused by candida is known as system candidiasis or candidemia.

Sometimes humans and the microorganism live with each other without harming each other and no symptoms of the disease are developed when the human immune system takes action against the germs or the germs become so large in number that the body shows the symptoms of the disease.

Fungemia usually occurs in those people who have decreased efficiency of the immune system or have a compromised immune system. This deficiency in the ability of the immune system may be because of neutropenia or some sort of cancer in the blood. Infliximab using the patient may have an increased chance of fungemia even if he is immunocompetent.

Sign and symptoms of Fungemia

Fungemia has a varying range of symptoms which may be mild or extreme. Fungemia can show many signs and symptoms.

These may include similar to those symptoms which occur in severe flow.

  • Chronic fatigue may also be the system.
  • Severe confusion. 
  • 0Non healing and persistent lesions and wounds.
  • Unusual and irregular discharge.
  • Sweating and itching.

Pathogenicity

Most of the blood infection-causing fungi come under the belt of fungemia but some of the species are especially well known for causing fungemia. In this candide, Albicans is the most common cause of fungemia which causes about 70% of fungemia.

Candida Glabrata comes after it with 10% while aspergillus and saccharomyces are the third and fourth common cause of fungemia respectively. But now the number of fungemia infections caused by saccharomyces boulardii, C. krusei, Candida tropicalis, and C. parapsilosis is also increasing. 

It is thought that it may be because of using a large amount of fluconazole and increasing the use of antibiotics. Candidaauris is also rising very rapidly in causing blood infection and is resistant to various drugs. It also causes other fungal infections in addition to fungemia.

Risk Factor

The following factors can increase the chance of fungemia.

  • Using a wide spectrum of antibiotic 
  • Other fungal infections in the body may also increase the chance of fungemia.
  • A patient of diabetes is also at increased risk of fungemia.
  • Immunosuppressed people also have a high risk of fungemia.
  • Use of a large number of antifungal drugs 
  • Severe sickness 
  • Uses an excess amount of steroid 
  • Multiple surgeries of the abdomen 
  • CVC and burns. While CVC stands for central venous catheter 
  • People who decreased the number of neutrophil cells of the blood are also at risk of fungemia.
  • These individuals have any transplanted organ in the body.  

Diagnosis of Fungemia

Fungemia is diagnosed via blood culture using etiologic agents. The blood culture technique made significant progress in the previous twenty years and is very effectively used in the detection of fungal diseases.

Isolation of fungi is also made with a non-radiometric and radiometric system as well as selectively cultured media and LCS. Some blood tests are also used in the detection of fungi in the blood.

  1. Laboratory abnormalities: in dogs and cats with candidiasis result from the underlying disease process (such as diabetes mellitus or systemic neoplastic disease) as well as the location and severity of the fungal infection. Laboratory abnormalities in dogs or cats with Candida UTIs may be absent, or there may be evidence of renal failure with azotemia and isosthenuria. 

Grossly, urine may contain flocculent white debris. Urinalysis may reveal proteinuria, pyuria, and, in some cases, hematuria and/or Candida fungal elements (see Case Example). Dogs and cats with disseminated candidiasis or Candida peritonitis frequently have had nonregenerative anemia and mild to marked neutrophilia with pandemic and toxic neutrophil changes (in contrast to other deep mycoses, where hematologic abnormalities are often mild or absent).

Lymphopenia may be present as a result of underlying immunosuppressive illness or drug therapy. Some dogs are thrombocytopenic and have coagulation abnormalities consistent with disseminated intravascular coagulation.

Findings on the serum biochemistry panel in dogs with disseminated candidiasis are variable and nonspecific but may include metabolic acidosis, moderate to severe hypoalbuminemia, and increased liver enzyme activities.

Diagnostic Imaging Plain thoracic radiographs in dogs with disseminated candidiasis may be unremarkable or show increased pulmonary interstitial opacity, thoracic lymph adenomegaly, and/or pleural or pericardial effusion.13,5,20 Abdominal ultrasound examination in dogs with Candida peritonitis or disseminated disease may reveal echogenic ascites fluid, mesenteric hyperechogenicity, changes consistent with pancreatitis, abdominal lymph adenomegaly, or increased echogenicity of the renal cortices of hepatic parenchyma. 

  1. Microbiological Tests

The definitive diagnosis of candidiasis requires visualization of the organism within lesions by cytologic or histopathologic examination and confirmation of its identity using culture.

  1. Cytological Examination

Candida blastospores, pseudohyphae, and true hyphae can be visualized in swab specimens from the ear canal (ear cytology); tape preparations from the skin; urine sediment, or other body fluids or ultrasound-guided aspirates of abdominal lesions.

Pathologic Findings

Gross pathologic findings at necropsy in animals with disseminated candidiasis include peritoneal or pleural effusion, enlarged and edematous lymph nodes, congestion, and necrotic whitish foci within affected organs, evidence of tissue thrombosis, and formation of a gray-white or yellow-green fibrin necrotic layer on affected mucosal surfaces. Concurrent underlying disease processes are also often identified.

Histopathology of affected tissues reveals yeasts, pseudohyphae, and septate hyphae with an associated inflammatory response that is composed primarily of neutrophils, macrophages, and lymphocytes. Multinucleated giant cells may also be present; pseudohyphae and hyphae predominate in invasive infections.

Evidence of blood vessel invasion, thrombosing vasculitis, and infarction may be seen, with multifocal mycotic granulomas in affected organs.

The organism is most readily visualized with special stains such as periodic acid–Schiff and Gomora’s methenamine silver. Immunohistochemistry has also been used to identify Candida within lesions.

When mixed infections with Candida and other bacteria are present, tissue gram stains may reveal bacterial rods and/or cocci in addition to gram-positive fungal elements.

Clinical observation:

  1. Thrush 

It looks like ulceration on the lower side of the tongue it appears on those patients which have the weak immune system the term fungemia is related to the cells having week immunity for example it appears in those patients having HIV infection its major study is on the horses but its epidemiology is not still discovered the blisters on the lips of the mouth are the indication of antifungal therapy further diagnose is done by different test.

  1. Systemic Candidiasis

Its clinical analysis is often nonspecific because it has different signs and symptoms in most cases an incurable fever the hematogenous Candidiasis can take place after the oral mucosa or gastrointestinal induction. Different diseases are caused by Candidiasis for example pneumonia arthritis etc.

The foal having Candidiasis also suffered from fungal keratitis and panophthalmitis. But

Candidiasis in human patients is also referred to as pathogenic.

There are two types of Arthritis diseases caused by fungi one is called one is called mono arthritis is caused by commensal fungi by surgical instrument and direct contact. The Other Arthritis is called polyarthritis.

It is different from monoarthritis by means propagation in both cases the diagnosis process is very difficult the septic arthritis caused by fungus is different from the infectious arthritis caused by bacterial pathogens.

The septic Arthritis can be distinguish from infectious arthritis by it signs for example fever nucleated cells count in the fluid of the human patient but the fungal arthritis looks more resemble with the noninfectious inflammatory arthritis than acute bacterial arthritis their culture cannot be e distinguish better fungal are tight ass looks more resemble that we done on infectious inflammatory arthritis then cute infectious bacterial arthritis their culture cannot be distinguished easily.

The role of fungus candida SPP in the gastric ulcer pathogenicity is still not determined in one study it was discover that candida SPP gather at the at the ulcer site mucosal layer of the Gastrointestinal of the foal that was died due to ruptured gastric intestine this research shows that these fungal pathogens have a role in ulcer of gastric intestine of foal the horses which are suffering from endometritis have 1 to 5% fungal infection are more likely to called fungal endometritis.

The study of the reproductive tract of horses have confirmed that low level of progesterone is also the reason for the pathogenicity e of this angle infection but the cytology study of this phenomena is still undiscovered

Treatment of Fungemia 

Treatment for neutropenic and non-neutropenic candidiasis is different in candidemia an iv echinocandins are used as initial therapy iv canoechinocadian includes caspofungin, micafungin, and anidulafungin, Fluconazole can also be used as an alternative treatment. It is given either orally or via intravenous therapy.

If there is decreased availability of antifungal or antifungal resistance drugs then amphotericin B can also be used as an appropriate alternative.

Treatment and Prognosis

Cutaneous and corneal infections are usually treated with a combination of topical antiseptics or antifungal medications and systemic antifungal drugs until lesions resolve.

Dogs and cats with Candida UTIs should initially be treated with antifungal drugs that achieve high concentrations in the urine, such as fluconazole with or without 5-flucytosine. Systemic antifungals alone may be adequate to resolve Candida UTIs in some animals, although the resolution has been reported in some animals in the absence of antifungal drug therapy.

Persistent infection may result from drug resistance, adverse effects of treatment that necessitate treatment discontinuation, or inadequate drug penetration into balls of fungus that line the bladder wall. Intravehicular treatment with 1% clotrimazole may be effective in these cases. Under anesthesia, the bladder is catheterized with a Foley catheter, emptied, then lavage with sterile saline.

The bladder is then filled with a 1% clotrimazole solution (e.g., 30 to 50 mL for a cat). The animal is rotated to promote contact of the solution with the uroepithelium, and after the solution has been in the bladder for an hour, the catheter is removed and the animal is allowed to recover. Treatment is continued weekly until Candida can no longer be isolated from the urine. Typically, one to four treatments are required.

Ultrasound-guided administration of clotrimazole via cystocentesis to a dog with Candida cystitis was described in one report.

Successful treatment of systemic candidiasis in dogs or cats is rarely described. One dog with Candida peritonitis was treated successfully by surgical exploration and lavage of the abdomen, placement of an abdominal drain, and intravenous fluconazole.

Also, aggressive supportive measures were required that included intravenous fluid therapy, fresh frozen plasma, antiemetics, gastroprotection, total parenteral nutrition, and antibacterial drugs for a suspected catheter-related infection.

Antifungal drugs other than fluconazole used to treat invasive candidiasis in human patients include amphotericin B or an echinocandin such as caspofungin, 32 both of which must be administered parenterally.

Antifungal Therapy:

Polyenes: streptomyces doses produce an antifungal agent called amphotericin b This antifungal agent binds with sterol in the membrane of the fungus the permeability of the membrane is increased allowing the cell content to be leaked out and cause the cell death.  

  1. some fungus resistant to this drug for example candida SPP fusarium c Albicans aspergillus fumigatus this drug amphotericin b has been known for 40 years but it’s use is not discovered and limited to only e toxic effect and infusion nephrotoxicity it binds with lysosomal membrane Renal tubular cells which are rich in cholesterol in their membrane causing the permeability increase and death of the cell different signs and symptoms of toxicity in horses are anemia fever hypersensitivity reactions if the dose of this agent it is reduced the treatment will be failed for adult horses the recommended dose is 0.1 to 0.6 mg per kg mixed with 5% dextrose solution IV for 30 minutes 1 to 4 times a week the administration of this dose has discover no side effects in the adult horse 30 days the drug amphotericin be has also other Complex form like amphotericin B lipid complex Liposomal amphotericin b come and amphotericin B colloidal dispersion these drugs had been used only a few times they have less nephrotoxic effect and they are effect in horses is not fully understood
  2. Azoles:This antifungal drug have different mode of action it binds with cytochrome P 450 enzymes of the fungal cell membrane and in hi what’s the synthesis of ergosterol this biomolecule is necessary component of the cell membrane structure of the fungus.
  3. The first Act azole antifungal was ketoconazole the effect of this drug when orally taken is very poor when it is mixed with 23% acid HCL its effect is increased Fluconazole is effective for candida SPP cryptococcus but it is ineffective for fungus like aspergillus and other dimorphic fungi like Blastomyces and histoplasma the Pharmacology of Fluconazole revealed that it is effectively observed when orally taken it dispersed effectively in cell surrounding fluid Synovial fluid Aqua humor and urine concentration is the same as the concentration in the serum which was taken from the administered animal in human the Fluconazole is not effective for fungal stains like c albicans and candida SPP and other drugs itraconazole is widely used for fungal rhinitis caused by Conidiobolus.
  4. it’s recommended dose is 3 mg per kg itraconazole suspension is effectively absorbed than the capsule form fungal keratitis is cured with the combination of itraconazole and dimethyl Sulphur oxide but it is concentration is not enough in the aqueous humor when it is mixed with the dimethyl Sulphur oxide but in local fungal treatment of c albicans chelating agents are preferred to itraconazole in human patients for the treatment of both yeast molds triazole and voriconazole effective voriconazole is the excellent effective in horses when orally taken and is safe to use and its concentration in the cerebrospinal fluid 30 to 50% of the plasma concentration the recommended dose in horses is 3 mg per kg some antifungal drugs micafungin and voriconazole have been in mice and human and not still studied in the horses

Complications

  • If fungemia is not treated then some of its types can cause a very diagnosed health problem.
  • People which are immunocompromised such as patients of AIDS are those who have a weak immune system because of excess use of steroid. The fungemia can be fatal and can kill the patient if it is not treated.
  • Complications may include inflammation and infection in different parts of the body.
  • Membranes which surround the brain may also be infected, a condition is known as meningitis 
  • Esophagitis, arthritis, endocarditis can also occur as fungemia complications.

Prevention of Fungemia

Prevention of candidiasis involves avoidance of excessive immunosuppression as well as discriminate use of antibacterial drugs, that can be personalized to the outcomes of culture and vulnerability whenever possible. Whether Candida species carried on the hands of humans can colonize dogs and cats is not known, but routine hand washing and the wearing of gloves when immunosuppressed animals are handled or intravascular devices are placed should minimize the chance of healthcare-associated infections. Although prophylactic antifungal drug treatment has been used to prevent invasive candidiasis in human high-risk groups, the low incidence of candidiasis in immunosuppressed dogs and cats does not warrant the use of prophylactic antifungal drugs in this group.

Public Health Aspects and Fungemia

Different diseases are caused by fungi which also cause complex diseases. Candida species (especially C. Albicans) are common causes of mucosal disease in humans. Since 2000, Candida has also emerged as an extremely important cause of invasive infections owing to the more widespread use of invasive medical devices and immunosuppressive drugs.

In hospitalized human patients, Candida is reportedly the fourth most common organism isolated from the bloodstream.

Although many human infections result from the invasion of tissues by commensal yeasts in the face of immune suppression, horizontal transmission of Candida and hospital-acquired infections have been described.

Whether Candida isolates from dogs or cats colonize humans is not known. Different antifungals have different effects on a different strain of fungi and different doses and precautions. Some fungi are also resistant to these antifungal agents. The effectiveness of the administration of these drugs is different when taken orally and intravascular 

 

Leave a Comment